miR-744-5p suppresses tumor proliferation and metastasis by targeting transforming growth factor-beta 1 (TGF-β1) in hepatocellular carcinoma (HCC)

Wei-Feng Huang(Fujian Medical University), Zhongjun Wu(The Affiliated Yongchuan Hospital of Chongqing Medical University)

Journal of Gastrointestinal Oncology

August 1, 2021

10.21037/jgo-21-319

Cited by 14

Related Papers

Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB

|Cell Death and Disease|2020|110

Angiotensin-Converting Enzyme Inhibition Attenuates Lipopolysaccharide-Induced Lung Injury by Regulating the Balance Between Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 and Inhibiting Mitogen-Activated Protein Kinase Activation

|Shock|2015|103

MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma

|Oncotarget|2015|77

PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1/miR-195-5p axis-dependent manner in hepatocellular carcinoma

|Journal of Experimental & Clinical Cancer Research|2024|49

CMPK2 accelerates liver ischemia/reperfusion injury via the NLRP3 signaling pathway

|Experimental and Therapeutic Medicine|2021|24